<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.tobaccoinduceddiseases.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Tobacco Induced Diseases - Most accessed articles</title>
        <link>http://www.tobaccoinduceddiseases.com</link>
        <description>The most accessed research articles published by Tobacco Induced Diseases</description>
        <dc:date>2012-04-19T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/10/1/6" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/10/1/4" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/2/3/133" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/5/1/16" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/8/1/8" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/5/1/6" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/4/1/12" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/8/1/4" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/10/1/5" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/2/1/3" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/10/1/6">
        <title>Development of the Tobacco Tactics logo: From thumb prints to press</title>
        <description>Background:
The purpose of this study was to describe the development and evaluation of the image-based Veterans Affairs (VA) Tobacco Tactics program logo and campaign character using principles of social marketing.
Methods:
Four cross-sectional surveys with open- and closed-ended questions were used to gather participant demographic information, smoking behavior, and feedback on the development and evaluation of the Tobacco Tactics program logo and campaign character. The first 3 surveys were conducted with 229 veterans, visitors, and staff to obtain feedback for the final logo and character choice. The fourth survey was conducted with 47 inpatient veteran smokers to evaluate the Tobacco Tactics manual which was illustrated with the logo and campaign character. Descriptive statistics and bivariate analyses comparing demographic characteristics and tobacco use variables to opinions about the pictures for each round of testing were computed.
Results:
After three rounds of testing to modify the logo and character choices based on participant feedback and survey data, the bulldog logo was chosen to represent the VA Tobacco Tactics program as it was viewed as strong and tough by the majority of participants. About 80% of the participants rated the manual highly on items such as logo, color, and pictures/illustrations. Almost 90% said they would recommend the manual to someone trying to quit smoking.
Conclusion:
Social marketing techniques that include consumer feedback to develop appealing tobacco cessation campaigns can increase consumer engagement and enhance the development of compelling tobacco cessation campaigns to compete with the influential marketing of tobacco companies.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/10/1/6</link>
                <dc:creator>Lee Ewing</dc:creator>
                <dc:creator>Carrie Karvonen-Gutierrez</dc:creator>
                <dc:creator>Devon Noonan</dc:creator>
                <dc:creator>Sonia Duffy</dc:creator>
                <dc:source>Tobacco Induced Diseases 2012, null:6</dc:source>
        <dc:date>2012-04-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-10-6</dc:identifier>
                                <prism:require>/content/figures/1617-9625-10-6-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2012-04-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/10/1/4">
        <title>Association of smoking or tobacco use with ear diseases among men: a retrospective study</title>
        <description>Background:
Health related behaviour specially smoking and tobacco in any form are major determinants of health and lead to health inequities. Tobacco leads to various health problems including ear, nose and throat diseases.ObjectiveTo determine the influence of smoking or tobacco use on ear diseases we performed a retrospective study among men.MethodOf 11454 subjects of different age-groups there were 4143 men aged 20-60 years who were evaluated for demographic variables, smoking/tobacco use and middle and internal ear diseases. Descriptive statistics and age adjusted logistic regression analyses were performed.
Results:
Among the 4143 men, 1739 (42.0%) were smokers or used tobacco. In smokers/tobacco users compared to non-users the age adjusted odds ratios and 95% confidence intervals (CI) for chronic suppurative otitis media were 1.13 (CI 0.96-1.34), acute otitis media 1.16 (CI 0.82-1.64), suppurative otitis media 1.21 (CI 0.79-1.84), otosclerosis 0.97 (CI 0.52-1.33) (p &gt; 0.05) and for overall middle ear diseases was 1.15 (CI 0.99-1.33, p=0.05). For internal ear diseases the age adjusted odds ratios were for sensorineural hearing loss 1.12 (CI 0.92-1.58), 0.12 (CI 0.42-0.93) for vertigo and tinnitus and overall internal ear diseases were 0.97 (CI 0.77-1.22, p=0.81). Among men 40-60 years there was a significantly greater risk for both middle ear (OR 1.73, CI 1.29-2.30) and internal ear diseases (OR 1.94, CI 1.24-3.04) (p &lt; 0.001).
Conclusion:
Smoking/tobacco use is significantly associated with greater prevalence of middle and internal ear diseases among middle-aged men in India.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/10/1/4</link>
                <dc:creator>Kiran Gaur</dc:creator>
                <dc:creator>Neeraj Kasliwal</dc:creator>
                <dc:creator>Rajeev Gupta</dc:creator>
                <dc:source>Tobacco Induced Diseases 2012, null:4</dc:source>
        <dc:date>2012-04-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-10-4</dc:identifier>
                                <prism:require>/content/figures/1617-9625-10-4-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2012-04-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/2/3/133">
        <title>Factors Related to Smoking Habits of Male Adolescents</title>
        <description>A cross-sectional study was conducted to identify the factors related to smoking habits of adolescents among secondary school boys in Kelantan state, Malaysia. A total of 451 upper secondary male students from day, boarding and vocational schools were investigated using a structured questionnaire. Cluster sampling was applied to achieve the required sample size. The significant findings included: 1) the highest prevalence of smoking was found among schoolboys from the vocational school; 2) mean duration of smoking was 2.5 years; 3) there were significant associations between smoking status and parents&apos; smoking history, academic performance, perception of the health hazards of smoking, and type of school attended. Peer influence was the major reason students gave for taking up the habit. Religion was most often indicated by non-smokers as their reason for not smoking. Approximately 3/5 of the smokers had considered quitting and 45% of them had tried at least once to stop smoking. Mass media was indicated as the best information source for the students to acquire knowledge about negative aspects of the smoking habit. The authors believe an epidemic of tobacco use is imminent if drastic action is not taken, and recommend that anti-smoking campaigns with an emphasis on the religious aspect should start as early as in primary school. Intervention programs to encourage behavior modification of adolescents are also recommended.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/2/3/133</link>
                <dc:source>Tobacco Induced Diseases 2004, null:133</dc:source>
        <dc:date>2004-09-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-2-3-133</dc:identifier>
                                <prism:require>/content/figures/1617-9625-2-3-133-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>133</prism:startingPage>
        <prism:publicationDate>2004-09-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/5/1/16">
        <title>Perceptions of hookah smoking harmfulness: predictors and characteristics among current hookah users
</title>
        <description>IntroductionTobacco cigarette smoking a well-known cause of cancer and other diseases. Hookah smoking is another form of tobacco use that has rapidly spread in the United State and Europe. This study assessed beliefs about the harmfulness of smoking hookah.
Methods:
We surveyed hookah users in all cafes that provided hookah to its customers in downtown San Diego, California and nearby areas. A total of 235 hookah users participated in this study.
Results:
Average age of study participants was 22 years, 57% were males, and 72% were not cigarette smokers. Whites were more likely to use hookah than the other ethnic groups (33%), older hookah users (26-35 years) were mostly males, and mint flavor of hookah tobacco was the most popular among a wide variety of flavors (23%). There was no significant difference in gender in relation to the wrong perception that hookah is less harmful than cigarettes, but those of Asian ethnicity were much less likely than other ethnic groups to believe that hookah is less harmful than cigarettes. More frequent users of hookah were more likely to believe that hookah is less harmful than cigarettes. The majority of hookah users (58.3%) believe hookah is less harmful than cigarette smoking.DiscussionCompared to cigarettes, there appears to be a lack of knowledge about the harmfulness of smoking hookah among users regardless of their demographic background. Education about the harmfulness of smoking hookah and policies to limit its use should be implemented to prevent the spread of this new form of tobacco use.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/5/1/16</link>
                <dc:creator>Khaled Aljarrah</dc:creator>
                <dc:creator>Zaid Ababneh</dc:creator>
                <dc:creator>Wael Al-Delaimy</dc:creator>
                <dc:source>Tobacco Induced Diseases 2009, null:16</dc:source>
        <dc:date>2009-12-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-5-16</dc:identifier>
                                <prism:require>/content/figures/1617-9625-5-16-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>16</prism:startingPage>
        <prism:publicationDate>2009-12-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/8/1/8">
        <title>Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals</title>
        <description>Background:
Nicotine replacement therapy (NRT) is the most common form of smoking cessation pharmacotherapy and has proven efficacy for the treatment of tobacco dependence. Although expectations of mild adverse effects have been observed to be independent predictors of reduced motivation to use NRT, adverse effects associated with NRT have not been precisely quantified.ObjectiveA systematic review and meta-analysis aimed to identify all randomized clinical trials (RCTs) of NRT versus inert controls and all observational studies to determine the magnitude of reported adverse effects with NRT.
Methods:
Searches of 10 electronic databases from inception to November 2009 were conducted. Study selection and data extraction were carried out independently in duplicate. RCTs were pooled using a random effects method with Odds Ratio [OR] as the effect measure, while proportions were pooled from observational studies. A meta-regression analysis was applied to examine whether the nicotine patch is associated with different adverse effects from those common to orally administered NRT.
Results:
Ninety-two RCTs involving 32,185 participants and 28 observational studies involving 145, 205 participants were identified. Pooled RCT evidence of varying NRT formulations found an increased risk of heart palpitations and chest pains (OR 2.06, 95% Confidence Interval [CI] 1.51-2.82, P &lt; 0.001); nausea and vomiting (OR 1.67, 95% CI 1.37-2.04, P &lt; 0.001); gastrointestinal complaints (OR 1.54, 95% CI, 1.25-1.89, P &lt; 0.001); and insomnia (OR 1.42, 95% CI, 1.21-1.66, P &lt; 0.001). Pooled evidence specific to the NRT patch found an increase in skin irritations (OR 2.80, 95% CO, 2.28-3.24, P &lt; 0.001). Orally administered NRT was associated with mouth and throat soreness (OR 1.87, 95% CI, 1.36-2.57, P &lt; 0.001); mouth ulcers (OR 1.49, 95% CI, 1.05-2.20, P &lt; 0.001); hiccoughs (OR 7.68, 95% CI, 4.59-12.85, P &lt; 0.001) and coughing (OR 2.89, 95% CI, 1.92-4.33, P &lt; 0.001). There was no statistically significant increase in anxiety or depressive symptoms associated with NRT use. Non-comparative observational studies demonstrated the prevalence of these events in a broad population.
Conclusion:
The use of NRT is associated with a variety of side effects. In addition to counseling and medical monitoring, clinicians should inform patients of potential side effects which are associated with the use of NRT for the treatment of tobacco dependence.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/8/1/8</link>
                <dc:creator>Edward Mills</dc:creator>
                <dc:creator>Ping Wu</dc:creator>
                <dc:creator>Ian Lockhart</dc:creator>
                <dc:creator>Kumanan Wilson</dc:creator>
                <dc:creator>Jon Ebbert</dc:creator>
                <dc:source>Tobacco Induced Diseases 2010, null:8</dc:source>
        <dc:date>2010-07-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-8-8</dc:identifier>
                                <prism:require>/content/figures/1617-9625-8-8-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2010-07-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/5/1/6">
        <title>School-based smoking prevention programs with the promise of long-term effects</title>
        <description>I provide a systematic review of trials of school-based smoking prevention programs that had at least 15 sessions, preferably with some in high school, that reported significant short-term effects, and that included long-term follow-up. This is supplemented with a description of some other programs that produce short-term effects that portend large long-term effects. I conclude that school-based programs can have long-term effects of practical importance it they: include 15 or more sessions over multiple years, including some in high school; use the social influence model and interactive delivery methods; include components on norms, commitment not to use, intentions not to use, and training and practice in the use of refusal and other life skills; and use peer leaders in some role. School-based programs of this type can reduce smoking onset by 25&#8211;30%, and school plus community programs can reduce smoking onset by 35&#8211;40% by the end of high school. Some early childhood programs that do not have smoking prevention as their main aim, including home nursing, the Good Behavior Game, the Positive Action program and others, seem to change the developmental trajectories of children so that they are less likely to engage in multiple problem behaviors, including smoking, as adolescents. This review makes it clear that effective school-based smoking prevention programs exist and can be adopted, adapted and deployed with success &#8211; and should be.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/5/1/6</link>
                <dc:creator>Brian Flay</dc:creator>
                <dc:source>Tobacco Induced Diseases 2009, null:6</dc:source>
        <dc:date>2009-03-26T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-5-6</dc:identifier>
                                <prism:require>/content/figures/1617-9625-5-6-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2009-03-26T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/4/1/12">
        <title>Tobacco use and susceptibility to bacterial infection</title>
        <description>Active smokers and those exposed to secondhand smoke are at increased risk of bacterial infection. Tobacco smoke exposure increases susceptibility to respiratory tract infections, including tuberculosis, pneumonia and Legionnaires disease; bacterial vaginosis and sexually transmitted diseases, such as chlamydia and gonorrhoea; Helicobacter pylori infection; periodontitis; meningitis; otitis media; and post-surgical and nosocomial infections. Tobacco smoke compromises the anti-bacterial function of leukocytes, including neutrophils, monocytes, T cells and B cells, providing a mechanistic explanation for increased infection risk. Further epidemiological, clinical and mechanistic research into this important area is warranted.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/4/1/12</link>
                <dc:creator>Juhi Bagaitkar</dc:creator>
                <dc:creator>Donald Demuth</dc:creator>
                <dc:creator>David Scott</dc:creator>
                <dc:source>Tobacco Induced Diseases 2008, null:12</dc:source>
        <dc:date>2008-12-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-4-12</dc:identifier>
                                <prism:require>/content/figures/1617-9625-4-12-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2008-12-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/8/1/4">
        <title>Destructive effects of smoking on molecular and genetic factors of periodontal disease</title>
        <description>Many epidemiological evidences have proven the association between smoking and periodontal disease. The causality can be further established by linking findings of traditional epidemiological studies with the developments in molecular techniques that occurred in the last decade. The present article reviews recent studies that address the effect of smoking on molecular and genetic factors in periodontal disease. Most findings support the fact that tobacco smoking modulates destruction of the periodontium through different pathways: microcirculatory and host immune systems, connective tissue, and bone metabolism. Although smokers experience an increased burden of inflammatory responses to microbial challenges compared to non-smokers, understanding the association between smoking and periodontal diseases involves substantial problems with respect to accuracy of measurements, and particularly, sampling of many subjects. It remains unclear whether genetic susceptibility to periodontal disease is influenced by exposure to smoking or the effect of smoking on periodontal disease is influenced by genetic susceptibility. Employment of molecular techniques may play a key role in further elucidation of mechanisms linking smoking and periodontal destruction, the direct relationship as environmental factors and indirect relationship through genetic factors.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/8/1/4</link>
                <dc:creator>Miki Ojima</dc:creator>
                <dc:creator>Takashi Hanioka</dc:creator>
                <dc:source>Tobacco Induced Diseases 2010, null:4</dc:source>
        <dc:date>2010-02-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-8-4</dc:identifier>
                                <prism:require>/content/figures/1617-9625-8-4-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2010-02-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/10/1/5">
        <title>Challenges in Global Improvement of Oral Cancer Outcomes: Findings from Rural Northern India</title>
        <description>Background:
In India, 72% of the population resides in rural areas and 30-40% of cancers are found in the oral cavity. The majority of Haryana residents live in villages where inadequate medical facilities, no proper primary care infrastructure or cancer screening tools and high levels of illiteracy all contribute to poor oral cancer (OC) outcomes. In this challenging environment, the objective of this study was to assess the association between various risk factors for OC among referrals for suscipious lesions and to design and pilot test a collaborative community-based effort to identify suspicious lesions for OC.
Methods:
Setting: Community-based cross sectional OC screening.Participants: With help from the Department of Health (DOH), Haryana and the local communities, we visited three villages and recruited 761 participants of ages 45-95 years. Participants received a visual oral cancer examination and were interviewed about their dental/medical history and personal habits. Pregnant women, children and males/females below 45 years old with history of OC were excluded.Main outcome: Presence of a suspicious oral lesion.
Results:
Out of 761 participants, 42 (5.5%) were referred to a local dentist for follow-up of suspicious lesions. Males were referred more than females. The referral group had more bidi and hookah smokers than non smokers as compared to non referral group. The logistic regression analysis revealed that smoking bidi and hookah (OR = 3.06 and 4.42) were statistically significant predictors for suspicious lesions.
Conclusions:
Tobacco use of various forms in rural, northern India was found to be quite high and a main risk factor for suspicious lesions. The influence of both the DOH and community participation was crucial in motivating people to seek care for OC.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/10/1/5</link>
                <dc:creator>Jyoti Dangi</dc:creator>
                <dc:creator>Taru Kinnunen</dc:creator>
                <dc:creator>Thanos Zavras</dc:creator>
                <dc:source>Tobacco Induced Diseases 2012, null:5</dc:source>
        <dc:date>2012-04-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-10-5</dc:identifier>
                                <prism:require>/content/figures/1617-9625-10-5-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2012-04-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/2/1/3">
        <title>The Pulmonary Surfactant: Impact of Tobacco Smoke and Related Compounds on Surfactant and Lung Development</title>
        <description>Cigarette smoking, one of the most pervasive habits in society, presents many well established health risks. While lung cancer is probably the most common and well documented disease associated with tobacco exposure, it is becoming clear from recent research that many other diseases are causally related to smoking. Whether from direct smoking or inhaling environmental tobacco smoke (ETS), termed secondhand smoke, the cells of the respiratory tissues and the lining pulmonary surfactant are the first body tissues to be directly exposed to the many thousands of toxic chemicals in tobacco. Considering the vast surface area of the lung and the extreme attenuation of the blood-air barrier, it is not surprising that this organ is the primary route for exposure, not just to smoke but to most environmental contaminants. Recent research has shown that the pulmonary surfactant, a complex mixture of phospholipids and proteins, is the first site of defense against particulates or gas components of smoke. However, it is not clear what effect smoke has on the surfactant. Most studies have demonstrated that smoking reduces bronchoalveolar lavage phospholipid levels. Some components of smoke also appear to have a direct detergent-like effect on the surfactant while others appear to alter cycling or secretion. Ultimately these effects are reflected in changes in the dynamics of the surfactant system and, clinically in changes in lung mechanics. Similarly, exposure of the developing fetal lung through maternal smoking results in postnatal alterations in lung mechanics and higher incidents of wheezing and coughing. Direct exposure of developing lung to nicotine induces changes suggestive of fetal stress. Furthermore, identification of nicotinic receptors in fetal lung airways and corresponding increases in airway connective tissue support a possible involvement of nicotine in postnatal asthma development. Finally, at the level of the alveoli of the lung, colocalization of nicotinic receptors and surfactant-specific protein in alveolar cells is suggestive of a role in surfactant metabolism. Further research is needed to determine the mechanistic effects of smoke and its components on surfactant function and, importantly, the effects of smoke components on the developing pulmonary system.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/2/1/3</link>
                <dc:source>Tobacco Induced Diseases 2004, null:3</dc:source>
        <dc:date>2004-03-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-2-1-3</dc:identifier>
                                <prism:require>/content/figures/1617-9625-2-1-3-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2004-03-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

